Atlas Trials

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

Clinical trial NCT05634811 · COMPLETED

Trial details

NCT number
NCT05634811
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lyme Disease
Start date
2022-12-12
Primary completion
2025-07-21
Enrollment
3547

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.